Piasecki to lead Torre Lazur U.S. as Breitenbach exits

Share this article:
Torre Lazur McCann has appointed Marci Piasecki chief executive for its U.S. operations following the resignation of Beverley Breitenbach. Piasecki, who previously headed East Hanover, N.J.-based Echo Torre Lazur, reports to Richard Nordstrom, chairman and chief executive of Torre Lazur McCann Worldwide. She heads Torre Lazur McCann U.S. offices in Parsippany and East Hanover, N.J., San Diego and Chicago.
Piasecki worked for Torre Lazur McCann from 1992-2001, handling GlaxoSmithKline oncology and vaccine accounts, before joining Hyphen, where she headed client services. She re-joined Torre Lazur McCann in November, 2004.
Torre Lazur McCann said Breitenbach had resigned her post and "separately will announce future plans." Breitenbach could not be reached for this story.
Share this article:

Email Newsletters

More in Business Briefs

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.

India's Marck gets FDA Warning Letter

Inspectors of Marck Biosciences found an array of problems during a October-November 2013 inspection, including mold near a sterile area that was so bad "the room had 'partially caved in.'"

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.